{"name":"Vascular Solutions LLC","slug":"vascular-solutions-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":147200000,"revenueGrowth":286.5,"grossMargin":0,"rdSpend":18358000,"netIncome":10464000,"cash":144873000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2015"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fresh Frozen Plasma (FFP)","genericName":"Fresh Frozen Plasma (FFP)","slug":"fresh-frozen-plasma-ffp","indication":"Coagulopathy due to multiple clotting factor deficiencies","status":"marketed"}]}],"pipeline":[{"name":"Fresh Frozen Plasma (FFP)","genericName":"Fresh Frozen Plasma (FFP)","slug":"fresh-frozen-plasma-ffp","phase":"marketed","mechanism":"Fresh Frozen Plasma replaces deficient clotting factors and other plasma proteins to restore hemostatic function in patients with coagulopathy or massive bleeding.","indications":["Coagulopathy due to multiple clotting factor deficiencies","Massive transfusion and dilutional coagulopathy","Reversal of warfarin in emergency settings (when prothrombin complex concentrate unavailable)","Thrombotic thrombocytopenic purpura (TTP) plasma exchange","Deficiency of vitamin K-dependent factors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOa1pRMi1EY0ZQTnp0a2hXcFgwRFhLaTB0OHVBb2tTS2dfUUJBekZiTk11b2hmRy16OVhDVnNiamlJNEtxeDVfR0xYOE5QejhTZ0J4NWxMSnNiWFBCWjRIVFZLWkN2UHZ6TEtrOG5adGVUX2RNX3g5aVg4aDhLSmFnNTNGSzhLdUFTMFF0elJReFRpMDM1Ry03MXppVGRXTFlqVFh6Z1VaUkRsaGJQTG5wVXo0R0JPa3VJUEhhREdiang5NXJLaWlKR1ZLSlFMdDlBVk1GYUpOVE00WnY5X2F5M0lLdzJuTlFxSlFrNkZ0NnZFcVcwVkxDQW5OVVlEZ0Jn?oc=5","date":"2025-10-23","type":"deal","source":"Business Wire","summary":"FillPoint Health, a Lyceum Health Company, Announces Exclusive Specialty Pharmacy Partnership with US Heart & Vascular - Business Wire","headline":"FillPoint Health, a Lyceum Health Company, Announces Exclusive Specialty Pharmacy Partnership with US Heart & Vascular","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbERQVFZET0lxckhWZlRkZm80elg2XzR3eTdRdVcxWnJsRWdEeFE3cTJIU3VKdm9vNGxUeWR6YVB6Y3dpN3hhaHhKQ0tjTFBtT0s3Mktqbm5Pc3ZzWnJHeVFhdnFRM2hNbW9rRzlRTWdjNFdab2gxSjFpTzNiNWdGZGJOMXdaemlZ?oc=5","date":"2023-07-31","type":"pipeline","source":"Private Equity Stakeholder Project PESP","summary":"Private Equity Healthcare Acquisitions – June 2023 - Private Equity Stakeholder Project PESP","headline":"Private Equity Healthcare Acquisitions – June 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQVXNzcHFZZkpxc1UyVDFTbUpBcTI5a0dKVVUwbUkyUHNXMlozempBMnhVWnFUWWZDTGhDeGtQZHRCT1RqTGttYWZ3Uy1LdEREWWlreVhSclpJMXFadmViLXdnMXBHTDJZblB5Vjlja2ZSS1NzaWREbVY4VjVjMF9OWURFQ0hOblcxNTR2T3F4LVFiekJycU1lemFkZHNLNjZ6TkdYd2I3YVlGS2d5MVRnWi1XSVdZLTJVdHhFZk05WVZaNkNKTXcw?oc=5","date":"2023-04-23","type":"deal","source":"Forbes","summary":"China Billionaire’s Grand Pharma Buys BlackSwan Vascular For $37.5 Million - Forbes","headline":"China Billionaire’s Grand Pharma Buys BlackSwan Vascular For $37.5 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQMElmUXA0MTBrdEJJcVZNcVlPRGRrZldaLV9GS0ZaUFE5MVh2TDczaTlFQndoYjZWU0RnWjFBcEt5NWtEQTA0V0MzZU5nVDF5eGc0eS1nWVJtU21DN29lZEVUbUM5MC1JMFRiZEJfOFhoeS1ZbUJJZnZ1MFpFeEFQUm1zVzBwdzRLVWlYS3F6ME1JRnA5eUh3RkFrNkpORzlPXzF2Sw?oc=5","date":"2016-04-26","type":"pipeline","source":"Fierce Pharma","summary":"Veniti says first use of its Vici Verto stent system a success - Fierce Pharma","headline":"Veniti says first use of its Vici Verto stent system a success","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":147200000,"revenuePeriod":"2015-12-31","revenueHistory":[{"value":147200000,"period":"2015-12-31"},{"value":38085000,"period":"2015-12-31"},{"value":36954000,"period":"2015-09-30"},{"value":37550000,"period":"2015-06-30"},{"value":34611000,"period":"2015-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":18358000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":10464000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":144873000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}